Impacts of the Zero-Markup Drug Policy on Hospitalization Expenses of Patients with Stroke in Western China: An Interrupted Time Series Analysis

被引:1
|
作者
Wu, Yanghaotian [1 ,2 ,3 ,4 ]
Han, Xuemei [4 ]
Qiu, Jingfu [1 ,2 ,5 ]
机构
[1] Chongqing Med Univ, Dept Social Med, Chongqing, Peoples R China
[2] Chongqing Med Univ, Sch Publ Hlth, Hlth Serv Management, Chongqing, Peoples R China
[3] Southwest Med Univ, Sch Publ Hlth, Dept Social Med, Luzhou, Peoples R China
[4] Lanzhou Univ, Inst Social Med & Hlth Management, Sch Publ Hlth, Lanzhou, Peoples R China
[5] Chongqing Med Univ, Sch Publ Hlth, Yixueyuan Rd, Chongqing 400016, Peoples R China
关键词
zero-markup drug policy; stroke; interrupted time series; hospitalization expenses; drug expenses; SECONDARY PREVENTION; HEALTH; EXPENDITURE; INCENTIVES; EVENTS; TRENDS;
D O I
10.2147/RMHP.S456977
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In 2016, an innovative medical pricing reform called zero -markup drug policy (ZMDP) was implemented in selected pilot cities in China, which focuses on curbing the unreasonable growth of medical expenses. This study aimed to evaluate the impacts of ZMDP on medical expenditure of stroke in western China. Methods: The quantitative data of inpatients diagnosed with stroke was extracted from the medical insurance system in 7 tertiary public hospitals. An interrupted time series (ITS) was used to analyze the instantaneous level and long-term trend changes hospitalization expenses per visit from January 2015 to November 2018. Results: A total of 22,407 stroke inpatients were extracted. The total hospitalization expense per visit had the highest proportion 20,000 CNY and above (33.66%). After the ZMDP, the median total hospitalization expense and western medicine expense per visit decreased by 631.74 CNY and 966.35 CNY, respectively (P <0.001). Before the policy, the total hospitalization expense, traditional Chinese medicine (TCM) expense, examination expense, treatment expense, laboratory expense and surgical expense per visit showed upward trends (P<0.05), while the anesthesia expense per visit showed a downward trend (P<0.001). When the policy was implemented, the anesthesia expense per visit instantaneously increased by 91.70% (P<0.001). After the policy, the total hospitalization expense, western medicine expense, TCM expense, treatment expense and surgical expense per visit changed from upward trends to downward trends (P<0.05). The anesthesia expense per visit changed from a downward trend to an upward trend (P<0.001), and the examination expense per visit maintained an upward trend (P=0.005). Conclusion: The economic burden of stroke inpatients decreased significantly with the implementation of the ZMDP, especially for the drug expenses. The medical service expenses increased significantly, reflecting the improvement in the value of medical staff's technical labor. However, the unexpected increase in the examination expenses was likely to be associated with the unreasonable medical compensation mechanism.
引用
收藏
页码:777 / 788
页数:12
相关论文
共 50 条
  • [1] Impact of the zero-markup drug policy on hospitalisation expenditure in western rural China: an interrupted time series analysis
    Yang, Caijun
    Shen, Qian
    Cai, Wenfang
    Zhu, Wenwen
    Li, Zongjie
    Wu, Lina
    Fang, Yu
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 (02) : 180 - 186
  • [2] Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis
    Wang, Junman
    Li, Peiyi
    Wen, Jin
    [J]. BMC HEALTH SERVICES RESEARCH, 2020, 20 (01)
  • [3] Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis
    Junman Wang
    Peiyi Li
    Jin Wen
    [J]. BMC Health Services Research, 20
  • [4] The impacts of China?s drug price zero-markup policy on medical expenditures and health outcomes
    Shi, Julie
    Liang, Lirong
    Hou, Manqi
    [J]. CHINA ECONOMIC REVIEW, 2023, 79
  • [5] Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis
    Guo, Xirui
    Xiao, Yao
    Liu, Huan
    Li, Qinchuan
    Jiang, Qian
    Liu, Chun
    Xie, Fangqing
    Wang, Hongju
    Yang, Fang
    Han, Xiao
    Yang, Hengbo
    Yang, Yong
    Ye, Yongqin
    Gan, XiaoHong
    Long, Enwu
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [6] Descriptive Analysis on the Impacts of Universal Zero-Markup Drug Policy on a Chinese Urban Tertiary Hospital
    Tian, Wei
    Yuan, Jiangfan
    Yang, Dong
    Zhang, Lanjing
    [J]. PLOS ONE, 2016, 11 (09):
  • [7] The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study
    Zhu, Zheng
    Wang, Junfeng
    Sun, Yan
    Zhang, Jiawei
    Han, Peien
    Yang, Li
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [8] The Financial Impact of the 'Zero-Markup Policy for Essential Drugs' on Patients in County Hospitals in Western Rural China
    Zhou, Zhongliang
    Su, Yanfang
    Campbell, Benjamin
    Zhou, Zhiying
    Gao, Jianmin
    Yu, Qiang
    Chen, Jiuhao
    Pan, Yishan
    [J]. PLOS ONE, 2015, 10 (03):
  • [9] The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis
    Wang, Ruilin
    Li, Xinya
    Gu, Xinchun
    Cai, Qian
    Wang, Yayong
    Yi, Zhan-Miao
    Chen, Li-Chia
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [10] A retrospective and prospective assessment of the zero-markup drug reform in China from the perspective of policy diffusion
    Deng, Jianwei
    Tian, Huilin
    Guo, Yilun
    Ma, Tengyang
    Sun, Yangjie
    Zhang, Shiyang
    Yang, Tianan
    Tian, Xu
    [J]. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2018, 33 (04): : E918 - E929